Maetta plans to rapidly start the production of this device for market introduction this fall.

Maetta moved in March 2013 to a new 15,000 ft2 manufacturing facility located in Varennes in Quebec, Canada, where it already manufactures medical instruments and aerospace components. This investment was required to continue its expansion in both medical device and aerospace markets.

“It is a great achievement by our team as we believe this is the first time FDA clearance has been obtained for an implantable device made by MIM,” said Yvan Beaudoin, president and CEO. “It is also very encouraging as Maetta is currently involved in the development of several implantable devices with various clients."

Maetta holds ISO 13485; 2003, AS9100: 2009 and ISO 9001: 2008 certifications. It is specialized in high-end materials, such as cobalt chrome, titanium alloys, and nickel super alloys.